Read More 1 minute read M&A News News Model N Completes Acquisition by Vista Equity Partners Key Highlights Model N acquired by Vista Equity Partners for $1.25 billion. Transaction includes $30.00 per share in… byChris-Anne RoqueJuly 4, 2024
Read More 1 minute read M&A News News Pharmaceutical Incyte Completes Acquisition of Escient Pharmaceuticals Key Highlights Incyte acquires Escient Pharmaceuticals for $750 million plus net cash. Acquisition includes EP262 and EP547, first-in-class MRGPR antagonists. Enhances Incyte’s Inflammation and Autoimmunity portfolio. Potential treatments… byChris-Anne RoqueMay 30, 2024
Read More 1 minute read M&A News News Model N Acquisition by Vista Equity Partners Key Highlights Extended multi-year agreement between Piedmont and Anthem Blue Cross and Blue Shield benefits over 400,000 members across… byChris-Anne RoqueApril 11, 2024